NEW YORK (GenomeWeb News) – Aston University, in Birmingham, UK, will collaborate in an EU-funded study aimed at finding biomarkers for human aging. Scientists at Aston's School of Life and Health Sciences will conduct proteomics studies of blood samples to find biomarkers related to aging for the MARK-AGE study, which is a five-year study funded with €12 million ($17.1 million) under the Seventh Research Framework Programme.
The study is being led by the University of Konstanz, in Germany, and will include a total of 26 other research groups from academia, business, and research centers, from 14 European countries.
The study will involve 5,000 volunteers from around Europe, and will include men and women between the ages of 35 and 74 years old, "making it one of the largest studies of biomarkers of its kind," the university said.
"This large-scale project aims to identify biomarkers of ageing and any associations with changes in health," the university's Associate Dean of Research, Professor Helen Griffiths, said in a statement.
The school said that the project is directly relevant to its Aston Research Centre for Healthy Ageing, which is an inter-disciplinary research center focused on prevention, treatment, and rehabilitation of age-related problems in vision, hearing, metabolic/vascular functions, and neurodegeneration.